Midterm results of endovascular treatment of superficial femoral artery disease with biodegradable stents: single-center experience.

Purpose: To assess the midterm efficacy of a biodegradable poly-l-lactic acid (PLLA) stent in the treatment of superficial femoral artery (SFA) occlusive disease.

Materials And Methods: Between June 2009 and April 2011, 35 de novo SFA lesions were treated with 43 biodegradable stents. This nonrandomized, retrospective, single-center study included patients with moderate or severe claudication, lower-limb rest pain, or ischemic ulceration restricted to the toes; symptoms were classified as Rutherford category 2 (48.

Carotid artery stent fracture identification and clinical relevance.

Background: This study was conducted to identify the prevalence, risk factors, and clinical relevance of carotid artery stent fracture.

Methods: Commercially available carotid stents were implanted in this prospective, observational study that began in January 2004. Indications included asymptomatic patients (stenosis >80%), symptomatic patients (stenosis >60%), and ulcerated lesions (>50%).

Comparing outcomes of carotid endarterectomy with international benchmarks: audit from an Italian vascular surgery department.

Background: The aim of this study was to compare the outcomes of carotid endarterectomy (CEA) in the current practice of our department of vascular surgery with international benchmarks.

Methods: In-patient data from 488 CEA performed in both symptomatic 145 (29.7%) and asymptomatic 343 (70.